In recent years, the development of nanotechnology has brought about the dawn of overcoming many problems of traditional clinical drugs such as low solubility, weak selectivity, biodistribution and poor pharmacokinetics. Currently, a variety of nanomaterials such as silica, liposomes, carbon materials, layered hydroxides, and polymers have been reported as carriers for drug delivery. However, these new drug delivery systems still have many defects. For example, direct mixing of the silica sol and the drug results in heterogeneous dispersion of the drug, thereby causing the drug release rate to be affected by the sample batch. Liposomal carriers are less stable and are easily cleared by the reticuloendothelial system, resulting in fewer…